Lamivudine and Zodovudine Tablet

Get a Price/Quote

MOQ : 5000 Boxes

Lamivudine and Zodovudine Tablet Specification

Appearance
White to off-white film coated tablet

Dosage Form
Tablet

Molecular Formula
Zidovudine: C10H13N5O4S, Lamivudine: C8H11N3O3S

Dosage
150 mg Zidovudine + 300 mg Lamivudine

Expiration Date
36 months from the date of manufacture

Indication
Antiretroviral, indicated for HIV-1 infection

Origin of Medicine
India

Storage
Store in a cool, dry place below 30C. Protect from light and moisture.

Salt Composition
Zidovudine & Lamivudine

Usage
Used in the treatment of HIV infection

Assay
NLT 98% and NMT 102%

Grade
Pharmaceutical Grade

Pacakaging (Quantity Per Box)
10 x 10 tablets per box

Medicine Type
Allopathic

CAS No
30516-87-1 (Zidovudine), 134678-17-4 (Lamivudine)

Lamivudine and Zodovudine Tablet Trade Information

Minimum Order Quantity
5000 Boxes

FOB Port
Mumbai

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
100000 Boxes UNITS Per Month

Delivery Time
45 to 60 days Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
AS PER BUYERS REQUIREMENT.

Main Export Market(s)
North America, Africa, Eastern Europe, Australia, Western Europe, Middle East, South America, Asia, Central America

Main Domestic Market
All India

Certifications
WHO GMP,ISO,FSSAI

About Lamivudine and Zodovudine Tablet

Lamivudine and Zidovudine Tablet (Custom Branding) is a highly recommended antiretroviral medication, masterfully formulated for optimum effectiveness in HIV-1 infection treatment. Manufactured by trusted suppliers in India, this polished pharmaceutical grade product enjoys favorable reviews for its reliable efficacy and competitive pricing. Each oral dose delivers 150 mg Zidovudine and 300 mg Lamivudine in white to off-white film coated tablets, presented in blister packs for clarity and protection. Regulatory approvals and export documents are readily available. Use strictly under medical supervision and as per prescription guidelines.

Optimal Application & Superior Advantages

Lamivudine and Zidovudine Tablets are administered orally, ensuring precise dosage and convenience. This combination therapy provides the advantage of enhanced viral suppression in the treatment of HIV-1 infection. For best results, it should be taken exactly as prescribed by a healthcare professional. The specific usage benefits patients needing potent antiretroviral action, contributing to improved health outcomes when incorporated into a supervised HIV treatment regimen.

Valued Supply, Secure Packaging & Fast Shipping

Backed by robust supply ability, Lamivudine and Zidovudine Tablets are reliably available for global export. Each batch is professionally packaged: 10 x 10 tablets in a blister pack inside a printed carton, ensuring product integrity. Competitive valuation aligns with industry standards, while express shipping options facilitate quick and secure delivery worldwide. All transactions can be managed with flexible payment terms to support dealers, wholesalers, and suppliers, ensuring seamless procurement experience.

FAQs of Lamivudine and Zodovudine Tablet:

Q: How should Lamivudine and Zidovudine Tablets be administered to patients?

A: Lamivudine and Zidovudine Tablets should be taken orally as directed by a healthcare professional, following the prescribed dosage instructions for optimum therapeutic effects.

Q: What is the primary benefit of using this tablet combination in HIV treatment?

A: This medication offers enhanced efficacy in suppressing HIV-1 infection, combining two potent nucleoside reverse transcriptase inhibitors to help improve patient outcomes under medical supervision.

Q: When should the tablets be used after opening the blister pack?

A: Once opened, the blister pack of Lamivudine and Zidovudine Tablets should be used within 30 days to ensure optimum potency and safety.

Q: Where can the Lamivudine and Zidovudine Tablets be exported from?

A: These tablets are exported from India, and are available with all necessary regulatory approvals and documentation for international markets.

Q: What packaging details and supply options are available for this product?

A: The tablets are supplied in a secure blister pack (10 x 10 tablets per box), professionally packaged in a printed carton, ensuring safe transit and express shipping worldwide.

Q: Who should avoid taking Lamivudine and Zidovudine Tablets?

A: Individuals with hypersensitivity to any of the formulations components should not use this medication and must consult a healthcare professional for alternative treatments.

Tell us about your requirement